What to do with non-responders to CGRP(r) monoclonal antibodies: switch to another or move to gepants?

Creative Commons License

Waliszewska-Prosół M., Vurallı D., Martelletti P.

Journal of Headache and Pain, cilt.24, sa.1, 2023 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Editöre Mektup
  • Cilt numarası: 24 Sayı: 1
  • Basım Tarihi: 2023
  • Doi Numarası: 10.1186/s10194-023-01698-8
  • Dergi Adı: Journal of Headache and Pain
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CINAHL, MEDLINE, Psycinfo, Directory of Open Access Journals
  • Anahtar Kelimeler: CGRP, Combination, Gepants, Responders, Switching
  • Gazi Üniversitesi Adresli: Evet

Özet

In this editorial we aim to provide potential therapeutic options in patients who do not benefit from treatment with CGRP(r) monoclonal antibodies. Based on current real-life studies and analysis of practical and economic aspects, we will analyze the potential benefits of changing CGRP-targeted treatment.